Preliminary experiments point out conolidine may inhibit distinct ion channels, lowering neuronal excitability and limiting pain signals. This system is especially relevant in neuropathic soreness, in which irregular signaling leads to persistent distress. On top of that, conolidine appears to influence G protein-coupled receptor (GPCR) pathways integral to ache https://janep616fvl0.rimmablog.com/profile